2008
DOI: 10.1016/j.bmc.2008.06.047
|View full text |Cite
|
Sign up to set email alerts
|

Discovery and stereoselective synthesis of the novel isochroman neurokinin-1 receptor antagonist ‘CJ-17,493’

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
19
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 59 publications
(20 citation statements)
references
References 15 publications
0
19
0
Order By: Relevance
“…[2] Numerous efforts have been made to develop methods to preparei sochromene and related cyclic ether structures, [3] but available approaches suffer from low yield or requirecomplex starting materials.…”
Section: Introductionmentioning
confidence: 99%
“…[2] Numerous efforts have been made to develop methods to preparei sochromene and related cyclic ether structures, [3] but available approaches suffer from low yield or requirecomplex starting materials.…”
Section: Introductionmentioning
confidence: 99%
“…On the other hand, synthetic isochromans are exemplified by the apoptosis inhibitor of vascular endothelial cells ISO-09 (6), [6] the anti-migraine drug PNU-142633 (7), [7] the commercial fragrance galaxolide (8) [8] and the novel neurokinin-1 receptor antagonist CJ-17,493 (9), [9] while the non-steroidal anti-inflammatory drug etodolac (10) [10] is an example of a synthetic commercial aryl pyran other than a benzo-fused heterocyclic derivative.…”
Section: Introductionmentioning
confidence: 99%
“…7 Synthetic isochromans include the isochroman-6-carboxamides PNU-109291 ( 7 ) and PNU-142633 ( 8 ), both selective 5-HT 1D agonists and anti-migraine agents, 8-10 and CJ-17,493 ( 9 ) a neurokinin-1 receptor antagonist with antiemetic properties. 11,12 …”
Section: Introductionmentioning
confidence: 99%